EUVIMEDEUVIMED entdecken
Crossref

In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus

Léa Sanchez, Maria Bitar, Quentin Herail, Delphine Dorchêne, Jean-Emmanuel Hugonnet, Michel Arthur iD, Jean-Luc Mainardi

Journal of Antimicrobial Chemotherapy · 2024

DOI: 10.1093/jac/dkae181 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2024. Verfasst von Léa Sanchez und 6 weiteren Autor:innen. Beteiligte Einrichtung: Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Paris F-75006, France. Hauptthemen laut MEDLINE: Mycobacterium abscessus, Microbial Sensitivity Tests, Anti-Bacterial Agents, beta-Lactams. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 20 Literaturangaben. Gefördert von: Vaincre la Mucoviscidose, l'Association Grégory Lemarchal, l’Association Grégory Lemarchal.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Mycobacterium abscessus has emerged as an opportunistic pathogen responsible for lung infections, especially in cystic fibrosis patients. In spite of the production of the broad-spectrum β-lactamase BlaMab, the carbapenem imipenem is recommended in the initial phase of the treatment of pulmonary infections. Here, we determine whether the addition of vaborbactam, a second-generation β-lactamase inhibitor belonging to the boronate family, improves the activity of β-lactams against M. abscessus.

Methods

The activity of β-lactams, alone or in combination with vaborbactam, was evaluated against M. abscessus CIP104536 by determining MICs, time-killing and intramacrophage activity. Kinetic parameters for the inhibition of BlaMab by vaborbactam were determined by spectrophotometry.

Results

The combination of vaborbactam (8 mg/L) with β-lactams decreased more than 8 times the MIC of amoxicillin (from >1024 to 128 mg/L) and 2 times the MICs of meropenem (from 16 to 8 mg/L) and imipenem (from 4 to 2 mg/L). The reduction of the MICs was less than that obtained with avibactam at 4 mg/L for amoxicillin (from >1024 to 16 mg/L, more than 64 times less) and for meropenem (from 16 to 4 mg/L, 4 times less). In vitro and intracellularly, M. abscessus was not killed by the meropenem/vaborbactam combination, in spite of significant in vitro inhibition of BlaMab by vaborbactam.

Conclusions

Inhibition of BlaMab by vaborbactam decreases the MIC of β-lactams, including that of meropenem. As meropenem/vaborbactam is clinically available, this combination offers an alternative therapeutic option that should be evaluated for the treatment of pulmonary infections due to M. abscessus.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium abscessusMicrobial Sensitivity TestsAnti-Bacterial Agentsbeta-LactamsBoronic AcidsMycobacterium Infections, NontuberculousDrug Synergismbeta-Lactamase InhibitorsHumansAnimalsMiceMicrobial Viability

Substanzen

Anti-Bacterial Agentsbeta-LactamsvaborbactamBoronic Acidsbeta-Lactamase Inhibitors

Autor:innen und Institutionen

  • Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université Paris Cité, Paris F-75006, France.
  • Assistance Publique-Hôpitaux de Paris, Centre-Université de Paris, Université Paris Cité, Service de Microbiologie, Hôpital Européen Georges Pompidou, Paris F-75015, France.

ORCID-Profile: Michel Arthur

Förderung

  • Vaincre la Mucoviscidose
  • l'Association Grégory Lemarchal
  • l’Association Grégory Lemarchal

Zitieren

APA

Sanchez, L., Bitar, M., Herail, Q., Dorchêne, D., Hugonnet, J. E., Arthur, M., & Mainardi, J. L. (2024). In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkae181

Vancouver

Sanchez L, Bitar M, Herail Q, Dorchêne D, Hugonnet JE, Arthur M, et al. In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus. Journal of Antimicrobial Chemotherapy. 2024. doi:10.1093/jac/dkae181

BibTeX
@article{Sanchez2024,
  author = {Sanchez, Léa and Bitar, Maria and Herail, Quentin and Dorchêne, Delphine and Hugonnet, Jean-Emmanuel and Arthur, Michel and Mainardi, Jean-Luc},
  title = {In vitro and intracellular activity of vaborbactam combined with β-lactams against Mycobacterium abscessus},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2024},
  doi = {10.1093/jac/dkae181}
}
Kostenlos starten →